WHO: Fatal H1N1v Infection In Brazil

 

#19,390

Overnight the World Health Organization published its latest Influenza at the human-animal interface summary and assessment, 7 October 2026, which describes one previously reported  H5N1 case from Cambodia, 4 recent H9N2 cases reported from Mainland China, and one fatal H1N1v case from Brazil.

The H1N1v case is unusual in that the adult female patient - who had (unspecified) pre-existing chronic conditions - died after a month-long hospitalization. Of note:  Her husband and three adult children also reported flu-like symptoms - were treated for a `viral infection' - but were never tested. 

According to the timeline provided by this report, the hospitalized case was only identified as having a novel flu (H1N1v) a week after her death.  As a result, epidemiological investigation wasn't begun until September 5th, roughly 7 weeks after she (and her family) first fell ill.

First, the WHO report, after which I'll return with more.

Swine influenza viruses in humans 

Influenza A(H1N1)v, Brazil

On 30 September 2026, Brazil notified PAHO/WHO of a laboratory-confirmed human infection with an influenza A(H1N1)v virus in an adult woman, with pre-existing chronic conditions, residing in the state of Santa Catarina. She developed symptoms of influenza-like illness on 16 July 2026 and sought medical attention on 20 July. 

Her husband and three adult children, who live in the same household,also experienced symptoms of an influenza-like illness; at that time, all were diagnosed, based solely on clinical examination, with a viral infection and received treatment.

  The woman, however, did not recover. On 27 July, the patient was hospitalized due to worsening respiratory symptoms. She received treatment, including the antiviral oseltamivir, and required intensive care, including ventilatory support. Despite intensive care, the patient passed away on 28 August.

A nasopharyngeal sample, collected on 29 July, tested positive for influenza A on 30 July and was subsequently subtyped as influenza A(H1N1) on 31 July. The sample was sent to the reference laboratory for respiratory viruses at the Oswaldo Cruz Institute (IOC/Fiocruz) in Rio de Janeiro for further characterization. On 4 September, genomic analysis identified an influenza A(H1N1)v virus.

According to information gathered during an epidemiological investigation conducted by municipal and state teams between 5 and 9 September, the patient had no history of travel or direct contact with swine. However, a possible indirect exposure to swine was identified through a neighbour who raises these animals for personal consumption.

Since 2015, twelve cases of human infection with swine-origin virus variants, including this one, have been detected within Brazil’s respiratory virus surveillance workflow.

This chronology illustrates just how difficult it can be to detect a novel virus, even when the patient is hospitalized with severe influenza. A few recent examples include:

• In November of 2025, Washington State reported the first known human infection with avian H5N5; a diagnosis that was delayed - according to an MMWR report - by  `early and repeated negative influenza test results from upper respiratory swab specimens'.

• In 2024, a Missouri patient was hospitalized with influenza A, and released, before being notified they had H5N1 (see Missouri DHSS: Human H5 bird flu case confirmed in Missouri). 

• Also in 2024, Australia treated a child with recent travel from India for severe flu, which resulted in respiratory failure. The child fell ill (in India) in late February, was hospitalized in Melbourne in early March, and was released after > 2 weeks. While respiratory samples were taken in early March, they weren't identified as H5N1 positive until mid-May.  

Complicating matters, most people experiencing mild or moderate flu symptoms are unlikely to seek medical care, and even when they do, they are often treated for a `viral illness' and never tested.  

We've seen past studies (see here, here, and here) suggesting that as few as 1 in 100 cases are identified in the community. 

In early 2025, the CDC issued a HAN: Accelerated Subtyping of Influenza A in Hospitalized Patients, requesting that all hospitalized patients with suspected influenza be subtyped within 24 hours. 

More recently, we saw Washington State: Updated guidance for novel influenza screening and influenza subtyping, which emphasized the importance of identifying those with acute respiratory illness (ARI) and specific epidemiologic risk factors.

The reality is, it takes a certain degree of luck to detect sporadic novel flu infections in the community. While better screening methods could improve detection rates, many mild and moderate infections will still likely fly beneath our radar. 

A reminder than anything we say about the current threat from H5N1, swine flu variants, MERS-CoV, or any other pandemic threat must carry an implied asterisk.

A disclaimer that says, ` * based on available, and likely incomplete, information. . . '.